Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET

NCT00057070 · View on ClinicalTrials.gov ↗

Study Summary

The adverse impact of tobacco use on disease prevalence and health care costs is well documented. Hence, finding effective ways to reduce tobacco dependence is an essential component of improving the outcomes, quality and efficiency of VHA care. The U.S. Public Health Service (PHS) Smoking Cessation Clinical Practice Guideline provides specific recommendations for treating tobacco dependence. Despite their strong evidence base, however, these recommendations have not been fully integrated into clinical practice within the VHA. Recent data suggest that logistical difficulties associated with identifying and linking smokers with appropriate treatments may explain why the PHS Smoking Cessation Guideline has not been more broadly implemented.

Interventions

  • PROCEDURE Smoking cessation information, collection, and dissemination

Study Locations (2)

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN — Minneapolis

Washington

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA — Seattle

Trial Details

FieldValue
Enrollment Target 1,900 participants
Start Date 2001-10
Est. Completion 2003-09
Phase NA

Sponsor

US Department of Veterans Affairs

158 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00057070

The ClinicalTrials.gov registry entry for NCT00057070 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 158 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention — of which Smoking cessation information, collection, and dissemination is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT00057070 reports 2 study locations spanning 2 distinct geographic areas — top geographies include Minnesota, Washington. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT00057070 about?

NCT00057070 is a clinical study titled "Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET". The adverse impact of tobacco use on disease prevalence and health care costs is well documented. Hence, finding effective ways to reduce tobacco dependence is an essential component of improving the outcomes, quality and efficiency of VHA care. The U.S. Public Health Service (PHS) Smoking Cessation...

What is the current status of trial NCT00057070?

This trial is currently completed. It is a NA study. The enrollment target is 1,900 participants. The study started on 2001-10. Estimated completion is 2003-09.

What conditions does trial NCT00057070 study?

This clinical trial studies the following conditions: Smoking Cessation, Randomized Controlled Trial. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT00057070?

The interventions under investigation include: Smoking cessation information, collection, and dissemination (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT00057070?

This trial is sponsored by US Department of Veterans Affairs, which has 158 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT00057070 being conducted?

This trial has 2 study locations across Minnesota, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial